Page last updated: 2024-08-23

idarubicin and Obesity

idarubicin has been researched along with Obesity in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's3 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baer, MR; Barcos, M; Block, AW; Ford, LA; Hyland, AJ; Lee, HJ; Licht, AS; Sait, SN; Wang, ES; Wetzler, M1
Avvisati, G; Bagnardi, V; Breccia, M; Cimino, G; Disalvatore, D; FoĆ , R; Latagliata, R; Lo-Coco, F; Loglisci, G; Mazzarella, L; Minotti, C; Pelicci, PG; Petti, MC; Testi, AM1
Chi, M; Estey, E; Lin, A; McQuary, A; Othus, M1
Helmchen, C; Hofmann, C; Machner, B; Neppert, B; Paulsen, M; Sander, T1

Other Studies

4 other study(ies) available for idarubicin and Obesity

ArticleYear
Is obesity a prognostic factor for acute myeloid leukemia outcome?
    Annals of hematology, 2012, Volume: 91, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Clinical Trials, Phase I as Topic; Cytarabine; Databases, Factual; Female; Humans; Idarubicin; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Obesity; Retrospective Studies; Treatment Outcome; Young Adult

2012
Increased BMI correlates with higher risk of disease relapse and differentiation syndrome in patients with acute promyelocytic leukemia treated with the AIDA protocols.
    Blood, 2012, Jan-05, Volume: 119, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Child; Child, Preschool; Female; Follow-Up Studies; Humans; Idarubicin; Infant; Infant, Newborn; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Recurrence, Local; Obesity; Overweight; Prognosis; Risk Factors; Survival Rate; Syndrome; Tretinoin; Young Adult

2012
Influence of obesity on efficacy and toxicity of induction chemotherapy in patients with newly diagnosed acute myeloid leukemia.
    Leukemia & lymphoma, 2013, Volume: 54, Issue:3

    Topics: Acute Disease; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Body Mass Index; Cytarabine; Daunorubicin; Disease-Free Survival; Dose-Response Relationship, Drug; Female; Fever; Humans; Idarubicin; Induction Chemotherapy; Leukemia, Myeloid; Male; Middle Aged; Multivariate Analysis; Neutropenia; Obesity; Outcome Assessment, Health Care; Prognosis; Remission Induction; Young Adult

2013
Pseudotumor cerebri as a reversible side effect of all-trans retinoic acid treatment in acute promyelocytic leukaemia.
    European journal of neurology, 2008, Volume: 15, Issue:7

    Topics: Acetazolamide; Adult; Anticonvulsants; Antineoplastic Agents; Female; Humans; Idarubicin; Leukemia, Promyelocytic, Acute; Obesity; Pseudotumor Cerebri; Spinal Puncture; Tretinoin

2008